Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A prime-boost HCV vaccine strategy induces durable and broad T cell responses, characteristic of those associated with viral control.

Original publication

DOI

10.1126/scitranslmed.3009185

Type

Journal article

Journal

Science Translational Medicine

Publisher

American Association for the Advancement of Science (AAAS)

Publication Date

05/11/2014

Volume

6